Aquisição de Alteplase 2 mg/2ml e Eptinezumab 100 mg/ml, ao abrigo do AQ 2023-671

ID 13276897 · Portal BASE
Price
Base Price
€21,082 .00
Effective Price
€889 .00 -95.8%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Braga, Braga
Bidder Count
—
Winner
Boehringer Ingelheim Portugal, Lda.
NIF 500293023
Company
Dates
Publication
11 Feb 2026
Celebration
04 Dec 2025
Contracting Entity
Unidade Local de Saúde de Braga, EPE
NIF 515545180
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 50 · MEDIUM RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
11 Feb 2026
Signing Date
04 Dec 2025
Days Late
69
Rule
A2/A3 late publication: 69 days after signing (threshold: 10)
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
21082.0
Total effective price
889.0
Ratio
0.0422
Direction
reduction
Rule
A9 price reduction: ratio 0.0422 outside [0.5, 1.5]
Detected 2026-03-06